KUROGRAFT - Trademark Details
Status: 710 - Cancelled - Section 8
Serial Number
77345125
Registration Number
3882001
Word Mark
KUROGRAFT
Status
710 - Cancelled - Section 8
Status Date
2017-07-07
Filing Date
2007-12-05
Registration Number
3882001
Registration Date
2010-11-30
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2010-02-09
Attorney Name
Law Office Assigned Location Code
L60
Employee Name
WILLIS, PAMELA Y
Statements
Goods and Services
Cosmetic products, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cement, which contain hormones and/or growth factors to support restoration and reconstruction in reconstructive or cosmetic surgery; materials for permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous soft tissue, in particular fatty tissue and muscle tissue, other than for medical purposes, namely, protein and/or peptide and/or polyalkylenoxide preparations; carrier materials of synthetic and/or natural origin for cosmetic purposes, namely, matrices, solutions, gels, pastes, microparticles, nanoparticles, beads and cements, in particular consisting of fibrin and/or polyethylene glycol for retention or increased release of peptides or proteins, in particular hormones and growth factors, i.e., substances which stimulate growth of an organism or maintain growth for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; pharmaceutical products and preparations, namely, protein and/or peptide preparations, in particular for locally supporting the formation or regeneration of missing or damaged body parts, in particular of hard or soft tissue, in particular skin or bone; pharmaceutical or medical formulations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements of synthetic and/or natural origin for medical purposes, namely, for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue, in particular comprising fibrin and/or polyoxyalkyleneoxides, namely, polyethylene glycol for retention or sustained release of peptides, proteins and/or allograft materials, in particular hormones, growth factors and/or demineralized bone matrix, i.e., substances which stimulate growth of an organism or maintain growth; healthcare preparations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; biomedical products and biotechnology products for medical purposes, namely, peptides and proteins like hormones and growth factors or allograft materials used to spur regrowth and formation and to repair tissue, namely, tissue of bone, skin, organs, tendons, ligament, cartilage; materials for medical purposes for permanent or temporary enlargement, filling, repair, stabilization, support and/or regeneration of hard or soft tissue, in particular bone, intervertebral disk, cartilage, fatty tissue and muscle tissue, namely, protein and/or peptide and/or polyalkylenoxide preparations; biocompatible permanent or temporary adhesives and sealants, in particular for human and animal organs, soft and hard tissue for medical purposes; biocompatible separating materials, namely, anti-adhesion materials for avoiding undesired adhesion of organs and/or soft parts for medical purposes; implants and transplants of human derived autologous or allograft materials; autologous and allograft soft tissue for cosmetic and medical purposes; autologous and allograft hard and soft tissue in particular bone for transplantation purposes, bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement
Goods and Services
Artificial tissue replacement for restoring, maintaining and/or improving the function of diseased or damaged human or animal tissue (tissue engineering); synthetic implants, and transplants and modified implants and transplants, tissue, cells and/or molecules for replacing and/or for supporting the function of missing or damaged body parts; synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes and diagnostic purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement; modified implants and transplants with engineered endogenous material, tissue, cells or molecules for replacing and/or for supporting the function of missing or damaged body parts
Pseudo Mark
KUROS GRAFT
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2017-07-07
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2017-07-07
Primary Code
010
Correspondences
Name
JODY H. DRAKE
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
2007-11-14 | 62805/2007 | Switzerland | True |
Trademark Events
Event Date | Event Description |
2007-12-10 | NEW APPLICATION ENTERED IN TRAM |
2007-12-11 | NOTICE OF PSEUDO MARK MAILED |
2008-03-14 | ASSIGNED TO EXAMINER |
2008-03-14 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2008-03-17 | NON-FINAL ACTION WRITTEN |
2008-03-17 | NON-FINAL ACTION E-MAILED |
2008-03-17 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2008-09-16 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2008-09-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2008-09-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2008-09-25 | SUSPENSION LETTER WRITTEN |
2008-09-25 | LETTER OF SUSPENSION E-MAILED |
2008-09-25 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
2008-11-07 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
2008-11-07 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2008-11-07 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2008-11-21 | FINAL REFUSAL WRITTEN |
2008-11-21 | FINAL REFUSAL E-MAILED |
2008-11-21 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2009-05-21 | EXPARTE APPEAL RECEIVED AT TTAB |
2009-05-21 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
2009-05-21 | EX PARTE APPEAL-INSTITUTED |
2009-05-21 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2009-05-21 | ASSIGNED TO LIE |
2009-05-23 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2009-05-23 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2009-07-21 | NON-FINAL ACTION WRITTEN |
2009-07-21 | NON-FINAL ACTION E-MAILED |
2009-07-21 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2009-12-17 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2009-12-17 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2009-12-17 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2010-01-07 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2010-01-07 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2010-02-09 | PUBLISHED FOR OPPOSITION |
2010-02-09 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2010-05-04 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2010-10-19 | TEAS PETITION TO AMEND BASIS RECEIVED |
2010-10-19 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
2010-10-20 | ASSIGNED TO PETITION STAFF |
2010-10-20 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2010-10-19 | NOTICE OF ALLOWANCE CANCELLED |
2010-10-21 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
2010-10-21 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
2010-11-30 | REGISTERED-PRINCIPAL REGISTER |
2017-07-07 | CANCELLED SEC. 8 (6-YR) |